Pfizer Inc. (PFE) announced that it has completed its acquisition of Excaliard Pharmaceuticals Inc., a privately owned biopharmaceutical company focused on developing novel drugs for the treatment of skin fibrosis, more commonly referred to as skin scarring.
In November 2011, Pfizer had agreed to acquire privately held Excaliard Pharmaceuticals in a move to enhance its drug pipeline. The financial terms of the deal were not disclosed, but Pfizer said it will make an upfront payment and contingent payments if certain milestones are reached.
For comments and feedback contact: editorial@rttnews.com
Business News
December 26, 2025 08:42 ET Third quarter economic growth data from some major economies including the U.S. were the main news in this holiday shortened week. GDP growth and industrial production data from the U.S. helped to boost morale, while the consumer confidence survey results were less upbeat. In Europe, the quarterly economic growth data from the U.K. drew attention, while the minutes of the Australian central bank’s latest policy session was in focus in Asia.